*Individual results may vary depending on adherence to diet and exercise. In an 84-week study that began with a 12-week intensive lifestyle intervention including diet, exercise, and counseling, use of tirzepatide (15mg) in patients without diabetes and with obesity or overweight (BMI >30) led to an average weight loss of 26.6% (compared to 3.8% weight loss on placebo).
†Eden's Weight Loss Warranty: If you follow your plan and do not lose 10% of your body weight within six months, you get your money back. See Terms of Service for additional details.
